Skip to main content
FDA approves dupilumab for treatment of prurigo nodularis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA approves dupilumab for treatment of prurigo nodularis
User login
Username
Password
Reset your password
Concept
Lead
score
Biologic Therapy
1
1
Prurigo Nodularis
0
0.99
Otolaryngology
0
0.64
Dermatitis
0
0.98
Pain Management
0
0.36
Atopic Dermatitis
0
0.97
Child
0
0.23
Europe
0
0.23
Pruritus
0
0.23
Myalgia
0
0.2
Eosinophilic Esophagitis
0
0.16
Asthma
0
0.12
Cornea and External Disease
0
0.12
Diarrhea
0
0.12
Urticaria and Angioedema
0
0.12
Bullous Pemphigoid
0
0.11
Conjunctivitis
0
0.11
Esophagitis
0
0.11
Geriatrics
0
0.11
Interleukin
0
0.11
Muscle
0
0.11
Nasopharyngitis
0
0.11
Pain
0
0.11
Rhinosinusitis
0
0.11
Steroids
0
0.11
Urticaria
0
0.11
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
0.9
Allergy & Clinical Immunology
0
0.6
Internal Medicine
0
0.8
Pediatrics
0
0.7
Edit Tags